Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $2.82 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
• Trump: Iran cannot have, in any way, shape, or form, a nuclear weapon
• Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James